LCD ID Number: L37205 Status: A-Approved
LCD Title: Chemotherapy Drugs and their Adjuncts
Geographic Jurisdiction: Michigan Other Jurisdictions
Original Determination Effective Date:
Original Determination Ending Date:
Revision Effective Date:
Revision End Date:
CMS National Coverage Policy:
Italicized font -represents CMS national NCD language/wording copied directly from CMS Manuals or CMS Transmittals. Contractors are prohibited from changing national NCD language/wording.
CMS Pub. 100-02 Medicare Benefit Policy Manual, Chapter 15, Covered Medical and Other Health Services, Section 50, Drugs and Biologicals
CMS Pub. 100-04 Medicare Claims Processing Manual, Chapter 12, Physician/Nonphysician Practitioners, Section 30.5, Payment for Codes for Chemotherapy Administration and Nonchemotherapy Injections and Infusions
CMS Pub. 100-04 Medicare Claims Processing Manual, Chapter 14, Ambulatory Surgical Centers, Section 10, General
CMS Pub. 100-04 Medicare Claims Processing Manual, Chapter 17, Drugs and Biologicals, Section 90.2, Drugs, Biologicals, and Radiopharmaceuticals
CR 9749: August 24, 2016, CPT G0498: Chemo extend IV infusion with pump
Sorry, you need to login or register to view additional sections of this Medicare policy.
All information on this web site is compiled directly from information obtained from the Center
for Medicare and Medicaid Services (CMS) and from its Contractors.
CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on
this web site. However, the ultimate responsibility for correct coding and claims submission lies with the
provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information
is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims.
Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.
No part of this web page or data displayed may be redistibuted or used without the express written consent of Wheaton Partners, LLC.
02/01/2023 08:04:45 188.8.131.52